Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Corinth MedTech
AddedFeb 15, 2024
UpdatedJun 18, 2026
Corinth MedTech

Corinth MedTech

Closed

Corinth MedTech: Innovating endoscopic surgery tools for BPH and AUB treatment.

HQ
San Jose, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Corinth MedTech, founded in 2014 and based in Cupertino, CA, is dedicated to advancing surgical tools for endoscopic procedures. The company's core mission is to improve patient outcomes through innovative medical technology. Their flagship product is a bipolar transurethral and transcervical resection system designed for the minimally invasive removal of tissue in male patients with benign prostatic hyperplasia (BPH) and female patients with abnormal uterine bleeding (AUB), fibroids, or polyps.

Notable figures associated with Corinth MedTech include experienced medical device professionals and investors focused on healthcare innovation. The company has achieved significant milestones, including regulatory approvals and successful clinical trials, which have validated the efficacy and safety of their resection system. Corinth MedTech's impact lies in providing less invasive surgical options that enhance recovery times and reduce complications for patients suffering from BPH and AUB.

Corinth MedTech - Similar Companies

Minerva Surgical logo

Minerva Surgical

Meditrina logo

Meditrina

Corinthian Ophthalmic logo

Corinthian Ophthalmic

Corveus Medical logo

Corveus Medical

corveusmedical.com

Koronis Biomedical Technologies logo

Koronis Biomedical Technologies

koronisbiotech.com

Providence Medical Technology logo

Providence Medical Technology

providencemt.com

Corza Medical logo

Corza Medical

corza.com

Intact Medical logo

Intact Medical

CoNextions Medical logo

CoNextions Medical

conextionsmed.com

Cormedics logo

Cormedics

cormedicscorp.com

Ionix Medical logo

Ionix Medical

Cambridge Endoscopic Devices logo

Cambridge Endoscopic Devices

Medical Engineering Innovations logo

Medical Engineering Innovations

mei-america.com

Control Medical Technology logo

Control Medical Technology

Uro-1 logo

Uro-1

uro1medical.com

Corinth MedTech - Quick Facts

Who are Corinth MedTech's competitors?

Companies similar to Corinth MedTech include Minerva Surgical, Meditrina, Corinthian Ophthalmic and Corveus Medical.

When was Corinth MedTech founded?

Corinth MedTech was founded in 2014.

Where is Corinth MedTech's headquarters located?

Corinth MedTech's headquarters is located in San Jose, CA, US.

When was Corinth MedTech's last funding round?

Corinth MedTech's most recent funding round was for $5M (USD) in December 2020.

How much has Corinth MedTech raised to-date?

As of Dec 30, 2020, Corinth MedTech has raised a total of $17M (USD).

Corinth MedTech - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Medical Devices
Geographic Exposure
  • Americas
Revenue
  • Transactional
Main Product
  • Surgical Tools
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified